{"id":"W3176983361","doi":"10.1038/s41591-021-01369-8","title":"A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease","year":2021,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":365,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia; McGill University","funders":"Genentech; Korea Health Industry Development Institute; Deutsches Zentrum für Neurodegenerative Erkrankungen; Agence Nationale de la Recherche; GHR Foundation; Japan Agency for Medical Research and Development; Avid Radiopharmaceuticals; F. Hoffmann-La Roche; National Institute on Aging; Alzheimer's Association; Eli Lilly and Company; National Institutes of Health; U.S. Department of Health and Human Services; Foundation for the National Institutes of Health","keywords":"Medicine; Asymptomatic; Placebo; Internal medicine; Cognitive decline; Oncology; Gastroenterology; Pathology; Disease; Dementia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007066426,0.001257051,0.001754629,0.0002670634,0.0003706628,0.0007062151,0.0006152305,0.001730197,0.003839887],"category_scores_gemma":[0.0008252685,0.0002973254,0.001343666,0.000192139,0.0006544477,0.0009110633,0.0002216359,0.002440493,0.0007290367],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008127391,"about_ca_system_score_gemma":0.0007690452,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009665135,"about_ca_topic_score_gemma":0.00227715,"domain_scores_codex":[0.9997494,0.00009810689,0.00001566103,0.00005199497,0.00001725312,0.00006758302],"domain_scores_gemma":[0.9996867,0.0000840609,0.0000250173,0.00001961779,0.0000195409,0.0001651116],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8882791,0.004735694,0.001270999,0.0006532227,0.001413381,0.0005566705,0.0001194815,0.0006927384,0.01992659,0.0007919138,0.003974197,0.07758599],"study_design_scores_gemma":[0.8620537,0.1184552,0.007020949,0.000151082,0.0008497929,0.0006636953,0.00009331223,0.001016675,0.002608521,0.001328051,0.005706516,0.00005259666],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9823704,0.007906334,0.0003717545,0.002405972,0.000965049,0.0003200714,0.0006525891,0.0001244967,0.004883287],"genre_scores_gemma":[0.9915808,0.0022529,0.0005088978,0.001583716,0.0001912715,0.0003072569,0.0007712957,0.00001478125,0.002789113],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003839887,"threshold_uncertainty_score":0.0128457,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04139425644428404,"score_gpt":0.3732302047329456,"score_spread":0.3318359482886616,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}